Adam Dubow Bristol Myers Squibb CO (BMY) insider trading activity

Adam Dubow is SVP,ChiefCompliance&EthicsOff. of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 13,777 shares of BMY, which is worth approximately $811,051. The most recent transaction as insider was on Jul 30, 2021, when has been sold 2,466 shares (Common Stock, $0.10 par value) at a price of $67.9 per share, resulting in proceeds of $167,441. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.8K

0% 3M change

0% 12M change

Total Value Held $811,051

Adam Dubow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 30 2021	SELL Open market or private sale	$167,441 $67.9 p/Share	2,466 Reduced 15.18%	13,777 Common Stock, $0.10 pa...
May 05 2021	SELL Open market or private sale	$200,271 $64.21 p/Share	3,119 Reduced 16.11%	16,243 Common Stock, $0.10 pa...
Mar 10 2021	SELL Other acquisition or disposition	-	36 Reduced 0.23%	15,895 Common Stock, $0.10 pa...
Mar 10 2021	SELL Payment of exercise price or tax liability	$116,376 $60.93 p/Share	1,910 Reduced 8.98%	19,362 Common Stock, $0.10 pa...
Mar 10 2021	BUY Other acquisition or disposition	-	718 Added 3.42%	20,297 Common Stock, $0.10 pa...
Mar 10 2021	BUY Exercise of conversion of derivative security	-	5,404 Added 21.43%	19,811 Common Stock, $0.10 pa...
Nov 24 2020	SELL Open market or private sale	$57,051 $63.39 p/Share	900 Reduced 5.59%	15,186 Common Stock, $0.10 pa...
May 22 2020	SELL Open market or private sale	$195,232 $61.01 p/Share	3,200 Reduced 16.59%	16,086 Common Stock, $0.10 pa...
Mar 10 2020	SELL Payment of exercise price or tax liability	$116,150 $57.93 p/Share	2,005 Reduced 9.42%	19,286 Common Stock, $0.10 pa...
Mar 10 2020	SELL Other acquisition or disposition	-	26 Reduced 0.16%	16,697 Common Stock, $0.10 pa...
Mar 10 2020	BUY Other acquisition or disposition	-	561 Added 2.68%	20,363 Common Stock, $0.10 pa...
Mar 10 2020	BUY Exercise of conversion of derivative security	-	5,007 Added 19.95%	20,091 Common Stock, $0.10 pa...
Dec 05 2019	SELL Open market or private sale	$102,329 $58.81 p/Share	1,740 Reduced 9.95%	15,749 Common Stock, $0.10 pa...
Mar 10 2019	SELL Other acquisition or disposition	-	286 Reduced 1.74%	16,153 Common Stock, $0.10 pa...
Mar 10 2019	SELL Payment of exercise price or tax liability	$60,743 $51.39 p/Share	1,182 Reduced 6.33%	17,489 Common Stock, $0.10 pa...
Mar 10 2019	BUY Exercise of conversion of derivative security	-	3,735 Added 17.0%	18,240 Common Stock, $0.10 pa...
Sep 03 2018	SELL Payment of exercise price or tax liability	$16,530 $60.55 p/Share	273 Reduced 1.76%	15,222 Common Stock, $0.10 pa...
Sep 03 2018	BUY Exercise of conversion of derivative security	-	797 Added 4.89%	15,495 Common Stock, $0.10 pa...

Also insider at

DAWN

Day One Biopharmaceuticals, Inc. Healthcare

GENERAL COUNSEL

Adam Dubow

SVP,ChiefCompliance&EthicsOff.

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BMY shares.

Notify only if

Value

Insider Trading

Get notified when an Bristol Myers Squibb CO insider buys or sells BMY shares.

Notify only if

Operation

Value

Type

News

Receive news related to BRISTOL MYERS SQUIBB CO

Track Activities on BMY

Account